However, the pathogenicity of other heterozygous PLIN1 null variants, identified in patients referred for evaluation of maturity onset diabetes of the young, hyperinsulinemic hypoglycemia, or type 2 diabetes, has recently been questioned by Laver et al. (6). The gene discussed is PLIN1; the disease is type 2 diabetes mellitus.